Literature DB >> 35021316

Computed Tomography Features of Lung Structure Have Utility for Differentiating Malignant and Benign Pulmonary Nodules.

Johanna M Uthoff1,2,3, Sarah L Mott3, Jared Larson1, Christine M Neslund-Dudas4,5, Ann G Schwartz6, Jessica C Sieren1,2,3.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a known comorbidity for lung cancer independent of smoking history. Quantitative computed tomography (qCT) imaging features related to COPD have shown promise in the assessment of lung cancer risk. We hypothesize that qCT features from the lung, lobe, and airway tree related to the location of the pulmonary nodule can be used to provide informative malignancy risk assessment.
METHODS: A total of 183 qCT features were extracted from 278 individuals with a solitary pulmonary nodule of known diagnosis (71 malignant, 207 benign). These included histogram and airway characteristics of the lungs, lobe, and segmental paths. Performances of the least absolute shrinkage and selection operator (LASSO) regression analysis and an ensemble of neural networks (ENN) were compared for feature set selection and classification on a testing cohort of 49 additional individuals (15 malignant, 34 benign).
RESULTS: The LASSO and ENN methods produced different feature sets for classification with LASSO selecting fewer qCT features (7) than the ENN (17). The LASSO model with the highest performing training area under the curve (AUC) (0.80) incorporated automatically extracted features and reader-measured nodule diameter with a testing AUC of 0.62. The ENN model with the highest performing AUC (0.77) also incorporated qCT and reader diameter but maintained higher testing performance AUC (0.79).
CONCLUSIONS: Automatically extracted qCT imaging features of the lung can be informative of the differentiation between individuals with malignant pulmonary nodules and those with benign pulmonary nodules, without requiring nodule segmentation and analysis. JCOPDF
© 2021.

Entities:  

Keywords:  artificial intelligence; cancer risk assessment; chronic obstructive pulmonary disease; machine learning; quantitative computed tomography

Year:  2022        PMID: 35021316      PMCID: PMC9166332          DOI: 10.15326/jcopdf.2021.0271

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  31 in total

1.  Feature selection and performance evaluation of support vector machine (SVM)-based classifier for differentiating benign and malignant pulmonary nodules by computed tomography.

Authors:  Yanjie Zhu; Yongqiang Tan; Yanqing Hua; Mingpeng Wang; Guozhen Zhang; Jianguo Zhang
Journal:  J Digit Imaging       Date:  2009-02-26       Impact factor: 4.056

Review 2.  Quantitative Computed Tomography Imaging Biomarkers in the Diagnosis and Management of Lung Cancer.

Authors:  Hyungjin Kim; Chang Min Park; Jin Mo Goo; Joachim E Wildberger; Hans-Ulrich Kauczor
Journal:  Invest Radiol       Date:  2015-09       Impact factor: 6.016

Review 3.  Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis.

Authors:  S Wasswa-Kintu; W Q Gan; S F P Man; P D Pare; D D Sin
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

4.  Probability of cancer in pulmonary nodules detected on first screening CT.

Authors:  Annette McWilliams; Martin C Tammemagi; John R Mayo; Heidi Roberts; Geoffrey Liu; Kam Soghrati; Kazuhiro Yasufuku; Simon Martel; Francis Laberge; Michel Gingras; Sukhinder Atkar-Khattra; Christine D Berg; Ken Evans; Richard Finley; John Yee; John English; Paola Nasute; John Goffin; Serge Puksa; Lori Stewart; Scott Tsai; Michael R Johnston; Daria Manos; Garth Nicholas; Glenwood D Goss; Jean M Seely; Kayvan Amjadi; Alain Tremblay; Paul Burrowes; Paul MacEachern; Rick Bhatia; Ming-Sound Tsao; Stephen Lam
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

5.  Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort.

Authors:  Ane Aamli Gagnat; Miriam Gjerdevik; Frode Gallefoss; Harvey O Coxson; Amund Gulsvik; Per Bakke
Journal:  Eur Respir J       Date:  2017-05-11       Impact factor: 16.671

6.  Quantitative CT assessment of emphysema and airways in relation to lung cancer risk.

Authors:  David S Gierada; Preethi Guniganti; Blake J Newman; Mark T Dransfield; Paul A Kvale; David A Lynch; Thomas K Pilgram
Journal:  Radiology       Date:  2011-09-07       Impact factor: 11.105

7.  A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules.

Authors:  Michael K Gould; Lakshmi Ananth; Paul G Barnett
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

8.  Risk of Lung Cancer Associated with COPD Phenotype Based on Quantitative Image Analysis.

Authors:  Ann G Schwartz; Christine M Lusk; Angela S Wenzlaff; Donovan Watza; Stephanie Pandolfi; Laura Mantha; Michele L Cote; Ayman O Soubani; Garrett Walworth; Antoinette Wozniak; Christine Neslund-Dudas; Amy A Ardisana; Michael J Flynn; Thomas Song; David L Spizarny; Paul A Kvale; Robert A Chapman; Shirish M Gadgeel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-07-06       Impact factor: 4.254

9.  Severity of pulmonary emphysema and lung cancer: analysis using quantitative lobar emphysema scoring.

Authors:  Kyungsoo Bae; Kyung Nyeo Jeon; Seung Jun Lee; Ho Cheol Kim; Ji Young Ha; Sung Eun Park; Hye Jin Baek; Bo Hwa Choi; Soo Buem Cho; Jin Il Moon
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

10.  Radiomics of Lung Nodules: A Multi-Institutional Study of Robustness and Agreement of Quantitative Imaging Features.

Authors:  Jayashree Kalpathy-Cramer; Artem Mamomov; Binsheng Zhao; Lin Lu; Dmitry Cherezov; Sandy Napel; Sebastian Echegaray; Daniel Rubin; Michael McNitt-Gray; Pechin Lo; Jessica C Sieren; Johanna Uthoff; Samantha K N Dilger; Brandan Driscoll; Ivan Yeung; Lubomir Hadjiiski; Kenny Cha; Yoganand Balagurunathan; Robert Gillies; Dmitry Goldgof
Journal:  Tomography       Date:  2016-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.